Hormone findings in the kisspeptin study
A 2015 study compared kisspeptin-10 and kisspeptin-54 in healthy men. The catalogue's Kisspeptin 10mg Pen is a separate supplier presentation. The study measured luteinizing hormone and follicle-stimulating hormone, commonly abbreviated LH and FSH. Those are specific physiological endpoints, rather than a clinical test of this pen. Kisspeptin physiological comparison.
The investigators reported similar gonadotrophin secretion with the two kisspeptin forms at the studied conditions. Similar measured secretion does not establish that a supplier pen is equivalent to either studied preparation. Kisspeptin physiological comparison.
Study size and participant population
This was a single-blinded, placebo-controlled study using intravenous administration, with five participants recruited to each dosing group. It therefore supplies a focused hormone-response comparison in healthy men. Kisspeptin physiological comparison.
LH and FSH measurements do not, in this study, establish a fertility outcome or a general human benefit for the pen. Kisspeptin physiological comparison.
Kisspeptin pen amount and peptide identity
The catalogue identifies a pre-filled pen marked 10mg. That is an amount expression; it does not identify kisspeptin-10 or kisspeptin-54. The research forms are distinguished by name in the paper, while the catalogue amount remains a field of this presentation. Kisspeptin physiological comparison.
The separate Kisspeptin vial provides the photographed label comparison. Its printed fields should stay attached to that vial. A similar name and 10mg amount do not establish which studied preparation a different pen contains or how it performs. Kisspeptin physiological comparison.
